NCT00344773View on ClinicalTrials.gov

First-line Treatment for Adenocarcinoma Patients With Epidermal Growth Factor Receptor (EGFR) Mutation

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Pulmonary Cancer
Interventions
DRUG

Gefitinib

250mg tablet oral tablet once daily

Trial Locations (2)

Unknown

Research Site, Seongnam-si

Research Site, Seoul

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY